AzTrials
AzTrials

Posterior Crossbite6vsENCT02798822

Maxillary and Mandibular Arch Response to RME: a Multicentric Randomized Controlled Trial

A study testing Rapid maxillary expansion in people with Posterior Crossbite, run by University of Genova at 3 sites in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Posterior crossbite is a common clinical condition often associated with transverse maxillary deficiency and functional mandibular shift. This frequent malocclusion is not self-correcting and can lead to the development of craniofacial asymmetries and mandibular dysfunction. Read more about this study

Who is it for?
Ages 8 to 10 years
Conditions the study is for
Posterior Crossbite
What is being tested?
Rapid maxillary expansion
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
3 sitesItaly
Study dates
Jun 2013to Apr 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patients in mixed dentition
  • Unilateral posterior crossbite at least of the first permanent molar
  • Upper deciduous second molars available as RME anchoring teeth

Who cannot join

  • Primary exclusion criteria
  • Previous orthodontic treatment
  • Hypodontia in any quadrant excluding third molars
  • Inadequate oral hygiene
  • Temporomandibular joint disorders
  • Craniofacial abnormalities
Show all 11Show fewer
  • Secondary exclusion criteria
  • Lack of records
  • Need for lingual arch
  • Lack of consensus
  • Need for other orthodontic treatment during rapid maxillary expansion

Trial locations and contacts

3 sites in 1 country.

Italy3 sites
  • Ortohdontic Department - Univesity of Genoa

    Genova, 16100

  • Ortohdontic Department - Univesity of Siena

    Siena

  • Orthodontic Department - University of Varese

    Varese

Other trials in Italy

About this study

Official title: Dental Arches Response to Haas-type RME Anchored to Deciduous vs Permanent Molars in Children With Unilateral Posterior Crossbite

Posterior crossbite is a common clinical condition often associated with transverse maxillary deficiency and functional mandibular shift. This frequent malocclusion is not self-correcting and can lead to the development of craniofacial asymmetries and mandibular dysfunction.

The aim of the current study was to evaluate maxillary and mandibular arch widths' response to RME when it is anchored to the upper second deciduous molars or to the upper first permanent molars and to create a decision-making protocol for RME therapy in mixed-dentition patients.

Read the detailed description

The effects of rapid maxillary expansion (RME) on the maxillary complex have been highly investigated,4 reporting a maximum maxillary intermolar and intercanine width increase of 6.7 mm and 5.3 mm,5 respectively, when RME is banded on upper first permanent molars.

Literature also reported cases of periodontal and endodontic damage on RME anchoring teeth; therefore, some authors have suggested banding RME on primary teeth and reporting also different mean intermolar (3.6-4.1 mm) and intercanine width increases (5-5.9 mm).

Few studies have investigated the changes in molar dental tipping and inclinations (on average from 3° up to 16.7°) following RME but comprised difficult (ie, barium sulfate solution) and more invasive examinations such as computed tomography and cone beam computed tomography (CBCT) Few articles concerning the indirect effects on mandibular arch following RME reported a low but statistically significant increase of lower intermolar (0.66-0.97 mm) and intercanine width (0.9 mm). Since no studies in the literature have analyzed the differences in permanent vs primary molars as anchoring teeth for RME, the decision to band the permanent deciduous molars did not follow a clinical protocol, but an individual decision was made for each patient based on clinician experience.

Being tested
Rapid maxillary expansion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rapid maxillary expansionProcedure or surgery

    When rapid maxillary expander was in-situ, patients waited 7 days before starting the screw activation of one quarter turn a day (0.22 mm) until overcorrection. Expansion was considered adequate when the occlusal surface of the first maxillary palatal cusp contacted the occlusal surface of the mandibular first molar facial cusp. When was achieved, rapid maxillary expander stayed in place for 10 months.

Study groups in NCT02798822
Study groupRoleWhat they receive
RME on upper first permanent molarsActive comparatorIntervention/Procedure: Rapid maxillary expansion. When RME was in situ, patients started the screw activation (Snap-lock expander screw, Forestadent, Pforzheim, Germany) of one-quarter turn a day (0.22 mm) until overcorrection was achieved (ie, the occlusal surface of the first maxillary palatal cusp contacted the occlusal surface of the mandibular first molar facial cusp), and the RME remained in place for 10 months. The screw was turned for 35 ± 6 days for Gr6, and the average treatment time was 12 ± 1.3 months.
Receives: Procedure: Rapid maxillary expansion
RME on upper second deciduous molarsActive comparatorIntervention/Procedure: Rapid maxillary expansion. When RME was in situ, patients started the screw activation (Snap-lock expander screw, Forestadent, Pforzheim, Germany) of one-quarter turn a day (0.22 mm) until overcorrection was achieved (ie, the occlusal surface of the first maxillary palatal cusp contacted the occlusal surface of the mandibular first molar facial cusp), and the RME remained in place for 10 months. The screw was turned for 41 ± 8 days, and the average treatment time was 12 ± 1.3 months.
Receives: Procedure: Rapid maxillary expansion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Crossbite correction (binary outcome yes/no: clinical evaluation in vivo and on digital dental casts)

    Measured: 5 months

Secondary outcomes (10)
  1. Crossbite correction stability (binary outcome yes/no: clinical evaluation in vivo and measured on digital dental casts)

    Measured: 10 months

  2. Canine angulation (degrees of transverse expansion measured on digital dental casts)

    Measured: 5 months

  3. Canine angulation (degrees of transverse expansion measured on digital dental casts)

    Measured: 10 months

  4. Molar angulation (degrees of transverse expansion measured on digital dental casts)

    Measured: 5 months

  5. Molar angulation (degrees of transverse expansion measured on digital dental casts)

    Measured: 10 months

  6. Molar expansion (mm of transverse expansion measured on digital dental casts)

    Measured: 5 months

  7. Molar expansion (mm of transverse expansion measured on digital dental casts)

    Measured: 10 months

  8. Canine Expansion (mm of transverse expansion measured on digital dental casts)

    Measured: 5 months

  9. Canine Expansion (mm of transverse expansion measured on digital dental casts)

    Measured: 10 months

  10. Upper and lower incisor angulation and rotation (changes in mm and degrees of dental angulation and rotation measured on digital dental casts and Dental digital X-ray)

    Measured: 10 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2016 (estimated)
  2. Study startJun 2013
  3. Primary completionFeb 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02798822
Sponsor's protocol ID
80911110
Acronym
6vsE
Status last verified
Jun 2016
First submitted
2 Aug 2013
Last updated
14 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Cerruto C, Ugolini A, Di Vece L, Doldo T, Caprioglio A, Silvestrini-Biavati A. Cephalometric and dental arch changes to Haas-type rapid maxillary expander anchored to deciduous vs permanent molars: a multicenter, randomized controlled trial. J Orofac Orthop. 2017 Sep;78(5):385-393. doi: 10.1007/s00056-017-0092-2. Epub 2017 Apr 10.

    PubMed 28397083

Questions about this trial

What is this clinical trial studying?

A study testing Rapid maxillary expansion in people with Posterior Crossbite, run by University of Genova at 3 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Crossbite correction (binary outcome yes/no: clinical evaluation in vivo and on digital dental casts) (time frame: 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02798822, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in